PositoAI

a positivity index

Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Latest News

BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics, Inc. Estimates – BMV:BBOT
TradingView · 23 Oct 2026
BridgeBio Oncology Therapeutics (BBOT) Stock Price Prediction for 2026, 2030-2040
Traders Union · 23 Oct 2026
BridgeBio Oncology Thera Is Maintained at Outperform by Oppenheimer
Moomoo · 21 Oct 2026
BridgeBio Oncology: The KRAS Opportunity Hidden In The Selloff (NASDAQ:BBOT)
Seeking Alpha · 19 Oct 2026
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Upgraded to "Sell" at Wall Street Zen
MarketBeat · 17 Oct 2026
BridgeBio Oncology Therapeutics (BBOT) Slips 4.60% to $3.11, Drifting Toward Key Support - ALMA Signal
https://www.dars.gov.et/ · 13 Oct 2026
Bridgebio Oncology Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
TradingView · 12 Oct 2026
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 12 Oct 2026
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Receives Consensus Rating of "Moderate Buy" from Analysts
MarketBeat · 08 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.